Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/12 → 10/30/15 |
Funding
- Covance: $3,500.00
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375SL 0.1 and 0.4 mg as an Adjunctive Therapy to Treatment-as-Usual in the Maintenance Treatment of Bipolar 1 Disorder
- Dubovsky, Steven (PI)
Project: Research